You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A 15 T Superconducting Magnet for 350 GHz, 1 MW Class Gyrotrons for Commercial Fusion Reactors
SBC: BRIDGE 12 TECHNOLOGIES, INC. Topic: C5630aC56-30a-273585Electron cyclotron resonance heating is a key fusion technology for: a) plasma heating; b) instability control, to stabilize instabilities such as those from Neoclassical Tearing Modes; and c) electron cyclotron assisted startup. Gyrotrons are a proven vacuum tube technology that can generate sufficient power during continuous operation to satisfy these requirements. In this Phase I ...
STTR Phase I 2023 Department of Energy -
C55-04a: Software for Automatic Control, Calibration and Validation of Quantum Processors
SBC: ATLANTIC QUANTUM CORP Topic: C5504aQuantum computers has the potential to revolutionize computing, solving problems in chemistry, material science and optimization that are beyond the reach of today's most powerful supercomputers. However, we are still in the early phase of the technology development, and today’s quantum hardware systems suffer from drift and imperfections and require frequent calibrations to operate properly. Th ...
STTR Phase I 2023 Department of Energy -
Additive Manufacturing of Sesquioxide Ceramic Thin-Disk Gain Media with a Tailored Dopant Profile for Short-Pulse, High Average Power Lasers
SBC: RADIATION MONITORING DEVICES, INC. Topic: C5431bThe Problem Being Addressed The laser-based electron accelerator is an innovative tool to obtain GeV to TeV electron energies for high-energy particle physics experiments. The development of high-power laser systems for these accelerators, however, puts stringent challenges on the very limits of the laser materials themselves. The enormous heat generated by the high power creates great thermal str ...
STTR Phase II 2023 Department of Energy -
Recyclable Polyesters Made from CO2
SBC: LOOP CO2, INC. Topic: C5423bThe massive scale of global plastics production, which reached 390 million metric tons in 2021, has resulted in significant environmental challenges, including carbon emissions and pollution. A staggering 75% of discarded plastic ends up in landfills, while a mere 9% is recycled, causing a considerable amount to enter our ecosystems. Therefore, it is crucial to create affordable biodegradable plas ...
STTR Phase II 2023 Department of Energy -
Ultra-Compact Heat Exchangers for SMR
SBC: PHYSICAL SCIENCES INC. Topic: C5436mStatement of the problem or situation that is being addressed. In the past, the cost and complexity of high temperature heat exchangers for nuclear reactors have been inversely proportional due to the difficulties inherent in manufacturing finely-detailed welded or brazed structures. To address this problem, additive manufacturing is being used to produce a heat exchanger with extremely large surf ...
STTR Phase II 2023 Department of Energy -
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care
SBC: PASCALL Systems, Incorporated Topic: 106Project Summary Surgery and acute post-operative pain are major contributors to persistent pain, chronic pain, and opioid dependence. Currently, there are no products on the market in the United States that can be used to monitor surgical nociception. Existing products use indicators that are susceptible to intraoperative influences such as blood loss, anesthetic drugs and antihypertensives. This ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Controlled Gradient Release of Biologics: Enhanced Nerve Conduit for Long‐Gap Injury Repair
SBC: Pioneer Neurotech Inc. Topic: 106Project Summary / Abstract Nerve injuries arising from trauma, disease, or as a surgical necessity, lead most often to permanent loss of some or all functions mediated by the injured nerves. 50,000 peripheral nerve procedures are performed every year in the US, and 300,000 across Europe. After complete transection of a nerve, the optimal clinical procedure for nerve repair remains the surgical end ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
SBC: OASIS PHARMACEUTICALS, LLC Topic: NHLBIDespite prevalent use of anti-platelet and anti-lipid therapies, stroke remains the third major cause of death and is the leading cause of adult disability in the US with an estimated cost in the range of $34 billion annually. Approximately 20% of the annual 795,000 stroke patients die within one year and 15-30% are permanently disabled. Antiplatelet therapy is mainly used for primary prevention o ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Developing a virtual reality guided acupuncture imagery treatment for Chronic low back pain
SBC: MASSACHUSETTS NEURO TECHNOLOGY, INC. Topic: NCCIHProject Summary Low back pain (LBP) is one of the most common reasons for physician visits in the USA. A substantial number of chronic LBP (cLBP) patients do not adequately respond to current treatment options. Thus, the development of new treatments for cLBP is urgently needed. The use of imagery to treat illness, including chronic pain, is one of the oldest medical practices. Although still unde ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration
SBC: CRIMSON BIOPHARM INC Topic: NCIPROJECT SUMMARY The epidermal growth factor receptor (EGFR) gene is mutated and/or amplified in majority of primary glioblastoma (GBM). While EGFR-mutant GBM cancer cells are dependent on EGFR signaling for survival, numerous small molecule EGFR tyrosine kinase inhibitors (TKIs) have failed to show efficacy in this disease. There are two main reasons for these failures: i) Many of these EGFR-TKIs ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health